Aditya Birla Nuvo gets CCI approval for Pantaloon deal
- Maharashtra: Building collapses in Thane district, several feared trapped
- Nation pays tribute to Abdul Kalam, funeral in Rameswaram on July 30
- SC bench differs on Yakub's execution, refers plea to larger bench
- 'Your indebted student': Kalam's advisor pays tribute to former President on Facebook
- Gurdaspur attack: GPS shows terror team, got drug cartel help too
The Competition Commission of India (CCI) has given the green signal to the takeover of Future group's Pantaloon brand business by Aditya Birla Nuvo (ABNL).
ABNL, through a subsidiary has proposed to acquire a majority of Pantaloon format business from Kishore Biyani-led Future group.
"... the Commission is of the opinion that the proposed combination is not likely to have an appreciable adverse effect on competition in India," the CCI order, dated December 21, said.
This order has come on an application filed on October 8.
The proposed combination relates to acquisition of business of Pantaloon Retail (India) Ltd by ABNL through the latter's subsidiary Peter England Fashions & Retail.
The CCI had in August termed as invalid an application seeking nod for this takeover deal as it yet to be approved by the boards of the two companies at that time.
In late April, Future Group had said that Aditya Birla Nuvo would infuse Rs 1,600 crore into its flagship 'Pantaloon'.
Orchid Chemicals gets CCI green signal for asset sale to Hospira
The Competition Commission of India (CCI) on Monday said it has approved a proposed sale by Orchid Chemicals and Pharmaceuticals (OCPL) of its certain assets to Hospira Healthcare.
Under the deal, OCPL has agreed to sell its Betaculum API (Active Pharmaceutical Ingredients) business among with its manufacturing facilities, as also another manufacturing facility in Aurangabad and an R&D facility in Chennai to Hospira Healthcare India a 100-per cent subsidiary of US-based Hospira Inc.